We investigated the effects of high plasma lipid levels on platelet adhesion and platelet thrombus formation in nonanticoagulated human blood on collagen fibrils at an arterial wall shear rate of 2600 seconds'
M
any studies indicate that hyperlipoproteinemia, which is a major risk factor of atherosclerosis and thrombosis, influences platelet function. 13 Hyperlipoproteinemia appears to be associated with an enhancement of platelet activity, as illustrated by the increased sensitivity of such platelets to aggregating agents. 13 However, the clinical relevance of these findings is questionable, since platelet aggregation tests are performed with anticoagulated platelet-rich plasma, and thus without the presence of blood flow and coagulation.
A recent study 4 evaluates the consequences of very high plasma lipid levels on platelet adhesion and thrombus formation on de-endothelialized abdominal rabbit aortas in perfusion chambers at controlled blood flow conditions and shows that hyperlipoproteinemia enhances thrombus formation. This finding led us to investigate whether this was also the case in humans with well-characterized type Ila and type lib hyperlipoproteinemias. We used an ex vivo model in which nonanticoagulated blood from patients and healthy individuals was perfused over type III collagen fibrils that were positioned in parallel-plate perfusion chambers. 5 Platelet adhesion, thrombus formation, and fibrin deposition were studied at an arterial wall shear rate of 2600 seconds" 1 . Such a shear rate may be encountered at the apex of moderately stenosed coronary arteries.
Methods

Subjects
Five patients classified as having type Ila hyperlipoproteinemia and 4 patients with type lib hyperlipoproteinemia according to World Health Organization criteria 6 were recruited. They were compared with 9 healthy volunteers from the clinical staff of our hospital. The main clinical characteristics of these subjects are presented in Table 1 . They had no history of thromboembolic disorders. None had ingested any lipid-lowering medications for at least 1 month before the perfusion procedure. All subjects stated they had not taken aspirin or other drugs known to affect platelet function in the last 8 days preceding the blood donation. None of the women were on oral contraceptive drug treatment. An oral informed consent was obtained from all subjects.
Blood Samples
Blood samples and perfusions were performed between 9 and 10 AM after overnight fasting. Blood was collected from an antecubital vein by using a 19-gauge butterfly (SFL, Abbott, France) and was placed in tubes for serum separation for lipid measurement ( Plasma levels of cholesterol and triglycerides were measured by enzymatic colorimetric tests (Boehringer Mannheim Automated Analysis, Boehringer Mannheim GmBH Diagnostica, Mannheim, FRG). Plasma levels of high-density lipoprotein (HDL) were measured after precipitation of low-density lipoprotein (LDL) and very-low-density lipoprotein (VLDL) by adding phosphotungstic acid and MgCl 2 to the serum (Boehringer Mannheim). In one patient with a high triglyceride level, HDL cholesterol (HDL-C) was measured in the supernatant obtained after ultracentrifugation for 18 hours at 4°C because the precipitation methodology was not efficient. VLDL and LDL were calculated by using the Friedewald formulas: VLDL=triglycerides/5 and LDL= total cholesterol-HDL-VLDL.
Thrombogenlc Surface
The thrombogenic surface consisted of purified fibrillar human type III collagen as previously described. 5 Collagen was purified from a pepsin extract of lyophilized human placenta by selective salt precipitation. Collagen concentration was measured by hydroxyproline assay. A fibrillar collagen suspension, obtained by dialysis for 48 hours, was spray-coated on plastic coverslips (TM Thermanox, Miles Laboratory, Naperville, 111) to a final density of =20 ^.g/cm 2 . A density of 5 /xg/cm 2 is sufficient to produce maximum platelet adhesion and thrombus formation. The collagen-coated coverslips were stored at 23°C for =16 hours before being used in perfusion experiments.
Perfusions
Perfusions were performed with a parallel-plate perfusion chamber as previously described. 5 After having collected blood samples for determination of hematologic parameters, nonanticoagulated blood was drawn by a pump from an antecubital vein for 3 minutes directly over type III collagen fibrils that were coated on a plastic coverslip positioned in the perfusion chamber. The pump was placed distally to the chamber. The blood flow rate was 10 mL/min which, given the geometric dimensions of the blood flow channel, corresponded to a wall shear rate at the collagen surface of 2600 seconds"
1 . Postperfusion and fixation were carried out at the same flow rate, first with a washout buffer (130 mmol/L NaCl, 2 mmol/L KC1, 12 mmol/L NaHCO 3 , 2.5 mmol/L CaCl 2 , 0.9 mmol/L MgCl 2 , and 5 mmol/L glucose, pH 7.4) for 20 seconds, then with a fixation solution (2.5% glutaraldehyde in 0.1 mol/L cacodylate, pH 7.4) for 40 seconds. The coverslip with the thrombotic deposits was subsequently removed from the chamber and was immersed in freshly prepared fixation solution at 4°C for 90 minutes. It was stored in 0.1 mol/L cacodylate/7% sucrose and embedded in Epon.
Morphometric Evaluation
Evaluation of thrombotic deposits was performed on Epon-embedded semithin sections (1 /xm thick) stained with toluidine blue and basic fuchsin. The sections were prepared as previously described 5 at an axial position 1 mm downstream from the flow inlet at the coverslip and perpendicular to the direction of blood flow. The morphometric analysis was according to Baumgartner and Muggli 7 and Sakariassen et al. 8 Platelet adhesion and fibrin deposition were quantified by light microscopy as the percentage of the total evaluated surface covered with adherent platelets (contact and spread platelets) and with fibrin, respectively. Sectional thrombus area was quantified by computer-assisted morphometry and was expressed as thrombus volume (micrometers cubed) per unit surface area (micrometers squared). 8 
Statistical Analysis
Statistical measurements were made using the PCSM program (Deltasoft, France). Results were expressed as median and range, and populations were compared using the Mann-Whitney U test. To assess the relations of platelet adhesion with the different lipid parameters, a multiple regression analysis with calculation of the standardized partial regression coefficient (;3) was performed. Differences of P<.05 were considered as significant.
Results
The main biological characteristics of patients and healthy individuals are given in Table 2 . Patients were classified as having type Ila or type lib hyperlipoproteinemia according to the criteria of the World Health Organization. 6 Type Ha hypercholesterolemic patients had high plasma levels of total and LDL cholesterol (LDL-C) (P<.01 versus the group of healthy individuals), whereas HDL-C, VLDL cholesterol (VLDL-C), and triglycerides were normal. Type lib hyperlipoproteinemic patients had significantly increased plasma levels of triglycerides, total cholesterol, LDL-C, and VLDL-C (P<.05). Individual plasma levels of the respective lipid parameters of the group of healthy subjects were all within the normal ranges. Also, there was no difference in hematocrit, leucocyte and platelet count, plasma fibrinogen, and von Willebrand factor levels between the patient groups and the group of healthy individuals (P>.IQ). Results of platelet-collagen adhesion and thrombus volumes after 3-minute perfusions at a wall shear rate of 2600 seconds" 1 are given in the Figure. Platelet-collagen adhesion in both groups of patients was significantly higher than in the group of healthy individuals (70. 
2).
The thrombus volume in type Ha and lib patients was not different from the group of healthy individuals (P>.10). The fibrin deposition was negligible in the three groups (<1%).
Discussion
Many studies show that hyperlipoproteinemia is associated with platelet hyperactivity as measured by the platelet aggregation device. 13 However, the clinical relevance (eg, thrombogenesis) of this finding is not known because platelet aggregation studies are performed with anticoagulated and nonflowing blood. A much more direct and relevant approach for investigating the influence of hyperlipoproteinemia on thrombogenesis is represented by perfusion studies, in which platelet-vessel wall and platelet-platelet interactions are studied under well-characterized blood flow conditions using nonanticoagulated blood. The thrombogenic effect of contraceptive drug treatment has been studied in this way. 9 Using this methodology, we have shown that plateletcollagen adhesion in flowing nonanticoagulated blood from patients with type lla and type lib hyperlipoproteinemia is significantly increased at a high arterial shear rate. The platelet-platelet interaction is apparently not affected by these metabolic disorders.
No studies have used this human method to evaluate the influence of hyperlipoproteinemia on platelet-vessel wall interactions. Badimon et al 4 have recently shown that platelet adhesion and thrombus formation measured on de-endothelialized rabbit aortas at a high shear rate (2600 seconds" 1 ) were increased in hyperlipidemic rabbits. Tandon et al, 10 using the Baumgartner perfusion device, de-endothelialized rabbit aortas as a thrombogenic surface, arterial flow conditions, and an-ticoagulated blood from patients with types Ha and lib dyslipidemia, report that only patients with type lib dyslipidemia have enhanced platelet adhesion. The platelet thrombus size was not significantly affected by the hyperlipoproteinemic state. 10 The present results confirmed the latter findings, showing that platelet adhesion and not thrombus formation is increased in patients with type lib hyperlipoproteinemia, but in a system making use of nonanticoagulated blood. In addition, we found that the platelet-collagen adhesion in nonanticoagulated blood from type Ha patients was enhanced as well.
The discrepancies between the human and rabbit studies are not due to differences in flow conditions. Both investigations were performed at arterial shear rate. Perfusion times were 5 and 20 minutes in the rabbit study, 30 minutes in the study performed by Tandon et al, 10 and 3 minutes in the present work. We chose a short perfusion period because the first minutes of the thrombus formation are of greatest importance for the in vivo consequences. Furthermore, the highest differences of thrombus formation between normal and hypercholesterolemic rabbits are seen with the shortest perfusion periods. 4 The disagreement between the human and rabbit studies is probably not due to differences in the nature of thrombogenic surfaces, since both Tandon et al 10 and Badimon et al 4 used subendothelium; we confirmed the finding of Tandon et al using nonprocoagulant collagen fibers. More presumably, differences are related to the different amounts of cholesterol in the diet, which resulted in plasma concentrations of 15 g/L total cholesterol in the rabbits compared with 3 to 4 g/L in the patients. Thus, the extremely high plasma cholesterol levels in the rabbits, which is not reached in humans, may explain this disagreement. 4 It is interesting to note that Tandon et al 10 showed that thrombus size was indeed increased when in vitro cholesterol-enriched platelets were used instead of platelets from hyperlipoproteinemic patients having a cholesterol-to-phospholipid ratio higher than those generally found in platelets from type Ha or lib patients. Thus, these results suggest that the effect of hyperlipoproteinemia on thrombus formation is dependent on the level of hyperlipoproteinemia and is detectable at markedly high plasma lipid levels.
Explanation of the enhanced platelet-collagen adhesion at a high arterial shear rate remains largely undefined. Previous work has shown that platelet hyperactivity in hyperlipoproteinemia could be due to the binding of lipoproteins (eg, LDL in type Ha and VLDL in type lib) to platelet membranes. 2 This may change the membrane fluidity, the enzymes involved in the synthesis of thromboxane A 2 , and/or the number of agonist receptors.
1112 Also, the sensitivity of cholesterol-rich platelets to thromboxane A 2 appears to be increased. 13 In our study, the enhanced platelet adhesion was apparently related to the plasma levels of both total cholesterol and VLDL-C.
Besides the effect of hyperlipoproteinemia on platelets themselves, other mechanisms may have played a role in the enhancement of the platelet adhesion. Reduction of erythrocyte deformability, which is seen in cholesterol-enriched erythrocytes, 14 promotes platelet adhesion to subendothelium. 15 von Willebrand factor, which strongly supports platelet adhesion at high wall shear rate, 16 was probably not affected in these patients because its plasma levels did not differ between the groups of healthy subjects and patients. Likewise, there were no differences between patients and subjects with respect to fibrinogen plasma levels. The increased platelet adhesion seen in types Ha and lib hyperlipoproteinemic patients may be involved in the accelerated development of atherosclerosis in these patients, besides other major mechanisms than the accumulation of lipid in the vessel wall. The consequences of intensive lipid-lowering therapy on regression of platelet adhesion and coronary arteriosclerosis remain to be investigated. 17 
